Literature DB >> 193011

Fulminant hepatic neoplasia after androgen therapy.

S T Mokrohisky, D R Ambruso, W E Hathaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 193011     DOI： 10.1056/NEJM197706162962414

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.

Authors:  Chi-Ming Chiu; Shiou-Hwei Yeh; Pei-Jer Chen; Ti-Jung Kuo; Ching-Ju Chang; Po-Jen Chen; Wan-Jen Yang; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-26       Impact factor: 11.205

2.  The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion.

Authors:  Min-Che Lin; Cheng-Chung Wu; Shao-Bin Cheng; Tse-Jia Liu; Fang-Ku P'eng
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

3.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

Review 4.  Adverse effects of anabolic steroids.

Authors:  R C Hickson; K L Ball; M T Falduto
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

Review 5.  Androgen therapy for anemia in elderly uremic patients.

Authors:  J F Navarro; C Mora
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Age and sex differences in bone metastasis of hepatocellular carcinoma in Japanese autopsy cases.

Authors:  T Fukusato; H Aoyama; W Mori
Journal:  Gastroenterol Jpn       Date:  1989-04

Review 7.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 8.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.